Source: FirstWord Pharma

4D pharma: 4D Pharma Pauses Recruitment of Patients to Studies Amid Administration

4D pharma said Friday that recruitment of new patients to clinical studies will be temporarily paused after administrators were appointed, as reported MarketWatch. The company said it plans to recom...

Read full article »
Annual Revenue
$100K-5.0M
Employees
25-100
Duncan Peyton's photo - CEO of 4D pharma

CEO

Duncan Peyton

CEO Approval Rating

89/100

Read more